World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
12666
World Ranking
4123
National Ranking
6

Overview

Sutee Yoksan is affiliated with Mahidol University in Thailand and has contributed extensively to the field of medicine, focusing primarily on public health, infectious diseases, and epidemiology. Their research spans multiple subfields including insect science and molecular biology.

The scientist's work covers a range of topics related to mosquito-borne diseases and control, viral infections and vectors, as well as malaria research and control. Additional areas of focus include virology and viral diseases, herpesvirus infections and treatments, advanced biosensing and bioanalysis techniques, and HIV research and treatment.

Frequent coauthors collaborating with Sutee Yoksan include Promsin Masrinoul, Terapong Tantawichien, Prasert Auewarakul, Nattachai Srisawat, and Duane J. Gubler.

Publications by Sutee Yoksan have appeared in several journals, with notable frequent venues being PLoS Neglected Tropical Diseases, Vaccine, Research Square, Scientific Reports, and the International Journal of Biological Macromolecules.

Recent papers authored or co-authored by Sutee Yoksan include:

  • Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus, 2020, Scientific Reports
  • Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine, 2021, International Journal of Biological Macromolecules
  • The helper oligonucleotides enable detection of folded single-stranded DNA by lateral flow immunoassay after HCR signal amplification, 2022, Talanta
  • Molecular characterization and geographical distribution of Zika virus worldwide from 1947 to 2022, 2023, International Journal of Infectious Diseases
  • Seroepidemiological study of Japanese encephalitis virus in Chiang Mai: Immunity and susceptibility 28 years after introduction of a vaccination programme, 2022, PLoS Neglected Tropical Diseases

Best Publications

  • Dengue: a continuing global threat

    Maria G. Guzman;Scott B. Halstead;Harvey Artsob;Philippe Buchy

  • Evaluation of diagnostic tests: dengue.

    Rosanna W. Peeling;Rosanna W. Peeling;Harvey Artsob;Jose Luis Pelegrino;Philippe Buchy

  • A variant in the CD209 promoter is associated with severity of dengue disease.

    Anavaj Sakuntabhai;Anavaj Sakuntabhai;Chairat Turbpaiboon;Chairat Turbpaiboon;Isabelle Casadémont;Ampaiwan Chuansumrit

  • Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses.

    Vu Thi Ty Hang;Nguyen Minh Nguyet;Vianney Tricou

  • Evaluation of commercially available anti-dengue virus immunoglobulin M tests.

    Elizabeth A Hunsperger;Sutee Yoksan;Philippe Buchy;van Vinh Chau Nguyen

  • Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

    Thomas P. Monath;Farshad Guirakhoo;Richard Nichols;Sutee Yoksan

  • Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

    Thomas P Monath;Karen McCarthy;Philip Bedford;Casey T Johnson

  • Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

    Arunee Sabchareon;Jean Lang;Pornthep Chanthavanich;Sutee Yoksan

  • Rapid and massive virus specific plasmablast responses during acute dengue virus infection in humans

    Jens Wrammert;Nattawat Onlamoon;Rama Akondy;Guey Chuen 'Oscar' Perng

  • Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

    Farshad Guirakhoo;Scott Kitchener;Dennis Morrison;Remi Forrat

  • Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation

    Marcin Kwissa;Helder I. Nakaya;Helder I. Nakaya;Nattawat Onlamoon;Jens Wrammert;Jens Wrammert

  • An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection

    Claire M. Midgley;Martha Bajwa-Joseph;Sirijitt Vasanawathana;Wannee Limpitikul

  • A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.

    Dennis Morrison;Thomas J. Legg;Christopher W. Billings;Remi Forrat

  • Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody.

    Elizabeth A. Hunsperger;Sutee Yoksan;Philippe Buchy;Vinh Chau Nguyen

  • Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.

    Maria G. Guzman;Thomas Jaenisch;Roger Gaczkowski;Vo Thi Ty Hang

  • Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.

    Arunee Sabchareon;Jean Lang;Pornthep Chanthavanich;Sutee Yoksan

  • Insecticide Susceptible/Resistance Status in Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus (Diptera: Culicidae) in Thailand During 2003-2005

    Nuananong Jirakanjanakit;Pornpimol Rongnoparut;Seeviga Saengtharatip;Theeraphap Chareonviriyaphap

  • Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case–control study in Nepalese children 5 years after immunization

    J.B. Tandan;Heechoul Ohrr;Young Mo Sohn;Sutee Yoksan

  • Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

    David W. Vaughn;Charles H. Hoke;Sutee Yoksan;Rebecca LaChance

  • Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

    Scott Kitchener;Michael Nissen;Peter Nasveld;Remi Forrat

  • Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness.

    Keswadee Lapphra;Anyarit Sangcharaswichai;Kulkanya Chokephaibulkit;Surapee Tiengrim

  • Change in Japanese encephalitis virus distribution, Thailand.

    Narong Nitatpattana;Audrey Dubot-Pérès;Meriadeg Ar Gouilh;Marc Souris

  • Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever.

    Punnee Butthep;Sirichan Chunhakan;Sutee Yoksan;Kanchana Tangnararatchakit

Frequent Co-Authors

Jean-Paul Gonzalez
Jean-Paul Gonzalez Georgetown University
Jean Lang
Jean Lang Sanofi (France)
Prida Malasit
Prida Malasit National Science and Technology Development Agency
Duncan R. Smith
Duncan R. Smith Mahidol University
Cameron P. Simmons
Cameron P. Simmons University College London
Scott B. Halstead
Scott B. Halstead Uniformed Services University of the Health Sciences
María G. Guzmán
María G. Guzmán Instituto de Medicina Tropical “Pedro Kourí”
Rosanna W. Peeling
Rosanna W. Peeling London School of Hygiene & Tropical Medicine
Duane J. Gubler
Duane J. Gubler Duke NUS Graduate Medical School
Bridget Wills
Bridget Wills University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related online degrees in nursing can open diverse career pathways. Many students start by exploring online ADN programs for non nurses, which provide foundational nursing skills essential for advanced studies.

Accelerated pathways are also popular, with numerous students choosing an accelerated NP program to quickly build expertise and move into impactful roles within healthcare. Specializations such as Acute Care Nurse Practitioner (ACNP) programs are particularly relevant for those wanting to work in critical care and immunology-related settings. More information about these is available through acnp programs.

Additionally, understanding the financial outlook is important. Many students and professionals consult data on how much do dnp nurses make to evaluate salary expectations and regional differences, helping to make informed decisions about their educational and career investments.

By exploring these related degrees and career options, aspiring immunology professionals can better tailor their education and training to meet evolving healthcare needs.

Best Scientists Citing Sutee Yoksan

Trending Scientists

Recently Published Articles